Emergence of dalbavancin, vancomycin, and daptomycin non-susceptible Staphylococcus aureus in a patient treated with dalbavancin: Case report and isolate characterization

alexandrossfakianakis shared this article with you from Inoreader Emergence of dalbavancin, vancomycin, and daptomycin non-susceptible Staphylococcus aureus in a patient treated with dalbavancin: Case report and isolate characterization Via Clinical Infectious Diseases Advance Access Abstract A patient with end-stage renal disease received 2 doses of dalbavancin for methicillin-resistant Staphylococcus aureus arteriovenous fistula infection and presented 5-weeks later with infective endocarditis secondary to vancomycin, daptomycin, and dalbavancin non-susceptible MRSA. Resistance was associated with walK and scrA mutations, reduced long-chain lipid content, and reduced membrane fluidity. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.